This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Alla Chem, LLC. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Dmitri Vladimirovich Kravchenko: An Innovator in Pharmaceutical Chemistry
Introduction
Dmitri Vladimirovich Kravchenko, based in Moscow, Russia, is an accomplished inventor known for his contributions to the field of pharmaceutical chemistry. With one patent to his name, he has made significant strides in the development of innovative compounds that play a critical role in regulating cellular homeostasis.
Latest Patents
Kravchenko's primary patent focuses on substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, which are antagonists of serotonin 5-HT receptors. His invention aims to simultaneously regulate calcium ion homeostasis in cells and includes methods for producing and using these compounds. The general formula of the compounds reflects a complex structure involving amino group substituents, phenyl and heterocyclic groups, showcasing the advanced nature of his work.
Career Highlights
Kravchenko is affiliated with Alla Chem, LLC, where he applies his innovative expertise to develop novel pharmaceutical solutions. He has demonstrated a strong commitment to advancing the field of drug discovery and therapeutic applications through his research and patent contributions.
Collaborations
Throughout his career, Dmitri has collaborated with fellow researchers such as Andrey Alexandrovich Ivashchenko and Alexandre Vasilievich Ivachtchenko. These partnerships have enhanced his research capabilities and expanded the scope of his innovative work in the pharmaceutical sector.
Conclusion
Dmitri Vladimirovich Kravchenko remains a notable figure in the realm of pharmaceutical innovations. His patent on substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles exemplifies his commitment to advancing therapeutic options and highlights his contributions to the scientific community. As he continues his work at Alla Chem, LLC, his ongoing research promises to impact the future of pharmaceutical chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile